Saturday, December 14, 2019
News on Pathogens and Preparedness
Global Biodefense
No Result
View All Result
  • Featured
  • Pathogens

    Tracing the Ancestral Genome of The Plague

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    Bacillus anthracis concept drawing

    Decontamination of Bacillus Spores from Drinking Water Infrastructure

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    red agar plate with cultured bacteria

    Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

    Turns Out, Bat Influenza Can Give You the Flu

    Turns Out, Bat Influenza Can Give You the Flu

    Crimean-Congo Hemorrhagic Fever

    Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

    Yersinia pestis

    Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens

  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe
  • Featured
  • Pathogens

    Tracing the Ancestral Genome of The Plague

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    Bacillus anthracis concept drawing

    Decontamination of Bacillus Spores from Drinking Water Infrastructure

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    red agar plate with cultured bacteria

    Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

    Turns Out, Bat Influenza Can Give You the Flu

    Turns Out, Bat Influenza Can Give You the Flu

    Crimean-Congo Hemorrhagic Fever

    Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

    Yersinia pestis

    Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens

  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Industry News

Second Partner Backs UH Effort to Develop Thermostable Ebola Vaccine

by Global Biodefense
1 Jun 2015
Dual Purpose Vaccine for Ebola and Rabies

Soligenix, Inc. last week announced a collaboration agreement with Axel Lehrer, PhD, of the UH Mānoa Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine (JABSOM); and Hawaii Biotech Inc. (HBI) to develop a heat stable subunit Ebola vaccine.

Dr. Lehrer, a co-inventor of the Ebola vaccine with HBI, has shown proof of concept efficacy with subunit Ebola vaccines in non-human primates.

Under the terms of the feasibility agreement, Soligenix will evaluate its proprietary vaccine thermostabilization technology, ThermoVax, licensed from the University of Colorado, to stabilize components of the vaccine.

Ultimately, the objective is to produce a thermostable Ebola vaccine for worldwide distribution that does not require cold storage.  ThermoVax has been previously demonstrated to enhance thermostability of both ricin (RiVax) and anthrax (VeloThrax) subunit vaccines. The initial work on the potential Ebola vaccine will focus on a single protein subunit antigen.

The most advanced Ebola vaccines involve the use of vesicular stomatitis virus (VSV) and adenovirus vectors – live, viral vectors that complicate the manufacturing, stability and storage requirements. Dr. Lehrer’s vaccine is based on highly purified recombinant protein antigens, circumventing many of these manufacturing difficulties.

Dr. Lehrer and HBI have developed a robust manufacturing process for the required proteins. Application of ThermoVax may allow for a product that can avoid the need for cold-chain distribution and storage, yielding a vaccine ideal for use in both the developed and developing world.

“There is a great need for a thermostable Ebola vaccine, particularly in areas of the world where Filoviruses are endemic and the power supply uncertain,” stated Dr. Lehrer.  “We are delighted to pursue this feasibility work with Soligenix and look forward to a long and productive collaboration.”

“Coupling Soligenix’s thermostabilization technology with Hawaii Biotech’s robust manufacturing processes is likely to yield a much needed vaccine to add to the world’s arsenal against infectious disease and we look forward to working with both Soligenix and JABSOM,” said Dr. Elliot Parks, President and Chief Executive Officer of HBI.

“We believe that creating a vaccine with enhanced stability at elevated temperatures, which can obviate the costs and logistical burdens associated with cold chain storage and distribution, has the potential to provide a distinct advantage over other Ebola vaccines currently in development,” stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix.

Tags: AdenovirusEbolaRicinThermostabilityVaccines
Previous Post

NPC1 Target Identified for Ebola Host-Based Therapeutics

Next Post

USDA Seeks Contract Support for Avian Influenza Response

Related Posts

Highly Sensitive Epigenomic Technology Combats Disease
Infectious Diseases

Highly Sensitive Epigenomic Technology Combats Disease

4 Dec 2019
Klebsiella pneumoniae
Antimicrobial Resistance

Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections

25 Nov 2019
Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria
Antimicrobial Resistance

Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria

11 Nov 2019
Diagnosing Sepsis in Minutes: Cytovale Raises $15 Million in Financing
Biodetection

Diagnosing Sepsis in Minutes: Cytovale Raises $15 Million in Financing

9 Nov 2019
Pathogens

Tracing the Ancestral Genome of The Plague

8 Nov 2019
Debiopharm Progresses in Their Stand Against Drug-Resistant N. gonorrhoeae
Antimicrobial Resistance

Debiopharm Progresses in Their Stand Against Drug-Resistant N. gonorrhoeae

8 Nov 2019
Load More
Next Post
Campylobacter Causing Disease In Chickens

USDA Seeks Contract Support for Avian Influenza Response

Headlines

  • Artificial Intelligence and Big Data Analytics for Biodefence: Implications for Threat Assessment And Biosurveillance
  • African Swine Fever Kills More Than 20 Wild Boar in Poland
  • Samoa Measles Outbreak: Death Toll Rises To 53, Mostly Children
  • OPCW Defends Syria Attack Conclusions After Document Leaks
  • Osama bin Laden’s “Anthrax Scientist” Freed by Malaysia

Recommended

  • Highly Sensitive Epigenomic Technology Combats Disease
  • Interview: Ambassador Bonnie Jenkins on 8 years of Combating WMD Terrorism
  • There’s No Such Thing as Just-in-Time Healthcare and Public Health Preparedness
  • Threat Detection in Your Pocket
  • Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections

Featured Partner

  • About
  • Contact
  • Privacy
  • Subscribe

© 2019 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • Pathogens
  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe

© 2019 Stemar Media Group LLC